Sponsors (2)
The bill uses significant federal funding to build public pilot-scale biomanufacturing hubs that can accelerate commercialization, local jobs, workforce training, and national-security tech transfer, but does so by excluding for-profit operators, imposing open-access/IP rules, and setting tight spending and sunset rules that create financial risk and uncertainty for some stakeholders.
Taxpayers authorize $462 million (FY2026–2030) to construct and equip pilot-scale biomanufacturing facilities, enabling those facilities to be built and start operations.
Universities, nonprofits, and innovators gain access to world-class pilot-scale facilities for prototyping and commercialization, lowering barriers to scale-up and speeding tech transition to market.
Rural communities and feedstock-proximate regions receive priority for regional facilities, which can create local jobs and strengthen regional supply chains.
Taxpayers face $462 million in authorizations plus administrative costs, with no guarantee the funded facilities or projects will succeed commercially.
Private companies and for-profit investors are excluded from being eligible recipients (limited to nonprofits, foundations, and universities), which may reduce direct private investment and commercialization incentive.
Mandated open-access rules and requirements that place some federally developed IP in the public domain may deter private firms from sharing proprietary processes or investing at the facilities.
Based on analysis of 2 sections of legislative text.
Creates a Commerce program to fund at least three regional nonprofit, open‑access bioindustrial technology maturation facilities to support pilot‑scale demonstration and early manufacturing.
Official title: To provide for the establishment of technology maturation facilities for the bioindustrial sector, and for other purposes.
Introduced May 20, 2026 by James Baird · Last progress May 20, 2026
Creates a Commerce Department program to fund and operate open‑access, nonprofit technology maturation facilities that help move bioindustrial technologies from lab to market. The program requires at least three regional, product‑agnostic centers that provide pilot‑scale equipment (including large commercial fermentation tanks and biomass processing) and supports planning, construction, operation, commercialization, and coordination with DOE and DOD. The Secretary of Commerce must run competitive grants/cooperative agreements for planning and implementation, define eligible nonprofit and academic entities, submit an implementation plan to Congress within 180 days, and focus facilities on advanced, scalable capabilities to accelerate U.S. bioindustrial manufacturing and market entry.